doxorubicin/cyclophosphamide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for doxorubicin/cyclophosphamide, covering 2018-09-18 to 2018-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer [Phase 2]